PL366301A1 - Neurotrophic tacrolimus analogs - Google Patents
Neurotrophic tacrolimus analogsInfo
- Publication number
- PL366301A1 PL366301A1 PL01366301A PL36630101A PL366301A1 PL 366301 A1 PL366301 A1 PL 366301A1 PL 01366301 A PL01366301 A PL 01366301A PL 36630101 A PL36630101 A PL 36630101A PL 366301 A1 PL366301 A1 PL 366301A1
- Authority
- PL
- Poland
- Prior art keywords
- neurotrophic
- tacrolimus analogs
- tacrolimus
- analogs
- neurotrophic tacrolimus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Packages (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25850000P | 2000-12-29 | 2000-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL366301A1 true PL366301A1 (en) | 2005-01-24 |
Family
ID=22980816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01366301A PL366301A1 (en) | 2000-12-29 | 2001-12-31 | Neurotrophic tacrolimus analogs |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1353671A4 (en) |
| JP (1) | JP2004527472A (en) |
| KR (2) | KR100794204B1 (en) |
| CN (1) | CN1293877C (en) |
| AR (1) | AR035411A1 (en) |
| AU (1) | AU2002231277B2 (en) |
| BR (1) | BR0116762A (en) |
| CA (1) | CA2433384A1 (en) |
| CZ (1) | CZ20032060A3 (en) |
| HU (1) | HUP0302521A3 (en) |
| IL (1) | IL156664A0 (en) |
| MX (1) | MXPA03005941A (en) |
| NO (1) | NO20032913D0 (en) |
| NZ (1) | NZ527209A (en) |
| PL (1) | PL366301A1 (en) |
| RU (1) | RU2288716C2 (en) |
| WO (1) | WO2002053159A1 (en) |
| ZA (1) | ZA200305806B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901023A0 (en) * | 2003-03-04 | 2003-03-20 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| JP2007518692A (en) * | 2004-01-20 | 2007-07-12 | アステラス製薬株式会社 | How to treat erectile dysfunction |
| EP1810675A1 (en) * | 2006-01-18 | 2007-07-25 | Institut Curie | Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421 |
| JP2009102226A (en) * | 2006-02-14 | 2009-05-14 | Meiji Milk Prod Co Ltd | Therapeutic agent for spinal cord injury |
| WO2010010127A1 (en) | 2008-07-23 | 2010-01-28 | Novartis Ag | Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation |
| EP2817009A1 (en) * | 2012-02-23 | 2014-12-31 | INSERM - Institut National de la Santé et de la Recherche Médicale | Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| GB201309375D0 (en) * | 2013-05-24 | 2013-07-10 | Chronos Therapeutics Ltd | Medical methods and compounds for medical use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU630866B2 (en) * | 1987-12-09 | 1992-11-12 | Fisons Plc | Macrocyclic compounds |
| GR1001225B (en) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Novel macrocyclic compositions and new application method thereof |
| US5541193A (en) * | 1991-09-05 | 1996-07-30 | Abbott Laboratories | Heterocycle-containing macrocyclic immunomodulators |
| GB9202196D0 (en) * | 1992-02-01 | 1992-03-18 | Fisons Plc | Method of treatment |
| GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
| GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
-
2001
- 2001-12-27 AR ARP010106058A patent/AR035411A1/en unknown
- 2001-12-31 CA CA002433384A patent/CA2433384A1/en not_active Abandoned
- 2001-12-31 CN CNB018228860A patent/CN1293877C/en not_active Expired - Fee Related
- 2001-12-31 EP EP01991558A patent/EP1353671A4/en not_active Withdrawn
- 2001-12-31 WO PCT/US2001/050419 patent/WO2002053159A1/en active IP Right Grant
- 2001-12-31 NZ NZ527209A patent/NZ527209A/en unknown
- 2001-12-31 KR KR1020037008787A patent/KR100794204B1/en not_active IP Right Cessation
- 2001-12-31 HU HU0302521A patent/HUP0302521A3/en unknown
- 2001-12-31 RU RU2003123493/15A patent/RU2288716C2/en not_active IP Right Cessation
- 2001-12-31 IL IL15666401A patent/IL156664A0/en unknown
- 2001-12-31 BR BR0116762-6A patent/BR0116762A/en not_active Application Discontinuation
- 2001-12-31 MX MXPA03005941A patent/MXPA03005941A/en active IP Right Grant
- 2001-12-31 JP JP2002554109A patent/JP2004527472A/en not_active Ceased
- 2001-12-31 CZ CZ20032060A patent/CZ20032060A3/en unknown
- 2001-12-31 PL PL01366301A patent/PL366301A1/en not_active Application Discontinuation
- 2001-12-31 AU AU2002231277A patent/AU2002231277B2/en not_active Ceased
- 2001-12-31 KR KR1020077003889A patent/KR20070030331A/en not_active Application Discontinuation
-
2003
- 2003-06-24 NO NO20032913A patent/NO20032913D0/en not_active Application Discontinuation
- 2003-07-28 ZA ZA2003/05806A patent/ZA200305806B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20032060A3 (en) | 2004-01-14 |
| EP1353671A1 (en) | 2003-10-22 |
| AR035411A1 (en) | 2004-05-26 |
| NO20032913D0 (en) | 2003-06-24 |
| KR20070030331A (en) | 2007-03-15 |
| ZA200305806B (en) | 2005-01-26 |
| NZ527209A (en) | 2005-09-30 |
| HUP0302521A2 (en) | 2003-11-28 |
| IL156664A0 (en) | 2004-01-04 |
| RU2003123493A (en) | 2005-01-20 |
| JP2004527472A (en) | 2004-09-09 |
| CN1538843A (en) | 2004-10-20 |
| EP1353671A4 (en) | 2004-07-14 |
| BR0116762A (en) | 2004-08-10 |
| MXPA03005941A (en) | 2005-02-14 |
| CN1293877C (en) | 2007-01-10 |
| CA2433384A1 (en) | 2002-07-11 |
| AU2002231277B2 (en) | 2006-11-30 |
| HUP0302521A3 (en) | 2007-03-28 |
| KR100794204B1 (en) | 2008-01-14 |
| RU2288716C2 (en) | 2006-12-10 |
| WO2002053159A1 (en) | 2002-07-11 |
| KR20040007431A (en) | 2004-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20011732A3 (en) | Elevator | |
| SG99909A1 (en) | Elevator | |
| AU145133S (en) | Rack | |
| AU2002360487A8 (en) | Acyclovir-peptide analogs | |
| TW478635U (en) | Building-block-assembled-type rack | |
| EG23909A (en) | Vatamin d, analogs | |
| IL158486A (en) | Nociceptin analogs | |
| AU146998S (en) | Rack | |
| PL366301A1 (en) | Neurotrophic tacrolimus analogs | |
| GB0022877D0 (en) | Analogues | |
| AU146997S (en) | Rack | |
| GB0006193D0 (en) | Platforms | |
| AU9174501A (en) | Novel mitogen activated kinase | |
| TW428699U (en) | Lampstand structure | |
| SI1414828T1 (en) | Antitumoral analogs | |
| TW561883U (en) | Structure for changing exercises | |
| AU141364S (en) | Rack | |
| TW444796U (en) | Bump-resistant structure for aid-lock | |
| TW485996U (en) | Multiple-functional movable floor structure | |
| GB0006388D0 (en) | Promoter | |
| TW459910U (en) | Combination structure for door-in-door | |
| GB0005151D0 (en) | None | |
| AU142390S (en) | Roof rack foot assembly | |
| GB0016622D0 (en) | Integral inflated groundsheet | |
| GB0015820D0 (en) | Integral inflated groundsheet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |